CD40 stimulation obviates innate sensors and drives T cell immunity in cancer

Byrne, Katelyn T., Vonderheide, Robert H.·2016·Cell Reports

DOI 10.1016/j.celrep.2016.05.058

Cited by (283)

Items 201–283 of 283

Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors
Lindsay K. Ward-Kavanagh, Kathleen M. Kokolus, Timothy K. Cooper, Aron E. Lukacher, Todd D. Schell · 2018 · Cancer Immunology Immunotherapy
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma
Marie J. Menard, Hiroyuki Yoda, Nicole M. Nasholm, Megumi J. Barata, Linyu Wang, Erin F. Simonds, Edbert D Lu, Shannon Wong‐Michalak, Lauren McHenry, Alvin Farrel et al. · 2025 · The Journal of Experimental Medicine
Inhibition of osteosarcoma lung metastases by β-glucan and CD40 agonist is mediated by activation of macrophages and NK cells
Pradeep Shrestha, Rejeena Shrestha, Eugenie S. Kleinerman · 2025 · Journal for ImmunoTherapy of Cancer
Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy
Barbara Geerinckx, Laure-Anne Marie Nicole Teuwen, Tiffany Foo, Timon Vandamme, Annabel Smith, Marc Peeters, Timothy Jay Price · 2023 · Expert Review of Anticancer Therapy
Current Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment
Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi, Ali‐Akbar Delbandi · 2023 · Interdisciplinary cancer research
Pre-Clinical Investigations of the Pharmacodynamics of Immunogenic Smart Radiotherapy Biomaterials (iSRB)
Michèle Moreau, Shahinur Acter, Lindokuhle M. Ngema, Noella Bih, Gnagna Sy, Lensa S. Keno, Kwok Fan Chow, Erno Sajo, Oscar Nebangwa, Jacques Walker et al. · 2023 · Pharmaceutics
Exogenous signaling repairs defective T cell signaling inside the tumor microenvironment for better immunity
Casey Moore, Joonbeom Bae, Longchao Liu, Huiyu Li, Yang‐Xin Fu, Jian Qiao · 2022 · JCI Insight
Immunotherapeutic Approaches in Cancer
Mahsa Keshavarz‐Fathi, Nima Rezaei · 2018 · Elsevier eBooks
Pancreatic cancer – What's next?
Roberto Salvia, Fabio Casciani, Elisabetta Sereni, Claudio Bassi · 2019 · La Presse Médicale
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Ceire A. Hay, Rina Sor, Ahron J. Flowers, Cynthia J. Clendenin, Katelyn T. Byrne · 2019 · Journal of Visualized Experiments
Leveraging cDC1 biology and function for enhanced immunotherapy
Ross W. Ward, Uddipan Kar, Sreekumar Balan, Nina Bhardwaj · 2026 · The Journal of Experimental Medicine
Agonistic anti-CD40 converts Tregs into Type 1 effectors within the tumor micro-environment
Vivien Ileana Maltez, Charu Arora, Rina Sor, Qiaoshi Lian, Robert H. Vonderheide, Ronald N. Germain, Katelyn T. Byrne · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Intratumoral expression of IL-12 and CD40 ligand (CD154) from plasmids generates antitumor responses that eliminate tumoral T regs
Gregory W. Ho, Alicia Santos, Jennifer L. Fields, Pamela C. Rosato, Mary Jo Turk, Nicole F. Steinmetz, Steven Fiering · 2025 · Scientific Reports
Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment
Vivien Ileana Maltez, Charu Arora, Kyle P. Gribbin, Breanna P Caruso, Margaret E. Haerr, Rina Sor, Qiaoshi Lian, Katie E. Blise, Shamilene Sivagnanam, Rosalie C. Sears et al. · 2026 · Immunity
CD4+ T Cells Mediate MHC-Deficient Tumor Rejection and Endothelial Cell Reprogramming
Samuel I. Kim, Margaret E. Haerr, Maryam Al-Ghezi, Canping Chen, Yi Zhang, Jackie L. Phipps, Charu Arora, Kyle P. Gribbin, G.T. Kim, Nune Markosyan et al. · 2025 · Cancer Immunology Research
Interrogating the CD27:CD70 axis in αCD40-dependent control of pancreatic adenocarcinoma
Awndre Gamache, Claire A Conarroe, Sara J. Adair, Todd W. Bauer, Frederic R. Padilla, Timothy N. J. Bullock · 2023 · Frontiers in Cell and Developmental Biology
Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice
Sadaf Aghevlian, Bo Wu, Marina Nura Raie, Spencer K. Tumbale, Aris J. Kare, Jai Woong Seo, Katherine W. Ferrara · 2021 · Nuclear Medicine and Biology
Interleukin 6 Drives Durable T Cell-Mediated Immunity to Pancreatic Cancer
Paige C. Arneson‐Wissink, Alexandra Q. Bartlett, Heike Mendez, Xinxia Zhu, Peter R. Levasseur, Parham Diba, Namratha Turuvekere Vittala Murthy, Jessica Dickie, Matthew McWhorter, Antony Jozić et al. · 2026 · Cellular and Molecular Gastroenterology and Hepatology
Emerging pharmaceutical therapies for targeting cholangiocarcinoma microenvironment and chemokine pathways
Armand N Yazdani, Michaela C. Pletsch, Abraham Chorbajian, David Zitser, Vikrant Rai · 2024 · Biocell
Impact of CD40 (rs1883832) and CD40L (rs1126535) gene variants on laryngeal cancer susceptibility and their association with serum biomarker levels of sCD40 and sCD40L
Alper Gümüş, Dilara Sönmez, Şeyda Demirkol, Mehmet Tolgahan Hakan, Ayşegül Verim, Yusufhan Süoğlu, İlhan Yaylım, Arzu Ergen · 2024 · PLoS ONE
Immunotherapy for Pancreatic Cancer
Yoshiaki Sunami, Simon Rieder, Patrick Michl, Jorg H. Kleeff · 2023 · Springer eBooks
Immuno-Oncology in Pancreatic Cancer
Nigel Balfour Jamieson, Colin William Steele · 2021 · Springer eBooks
Multiplex spatial systems analysis of local nanodose drug responses predicts effective treatment combinations of immunotherapies and targeted agents in mammary carcinoma
Zuzana Tatárová, Dylan C. Blumberg, James E. Korkola, Laura M. Heiser, John L. Muschler, Pepper J. Schedin, Sebastian W. Ahn, Gordon Brent Mills, Lisa M. Coussens, Oliver H. Jonas et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
CD4 memory T cells orchestrate therapy-responsive immune niches in colorectal cancer liver metastases
Maud Mayoux, Gioana Litscher, Fabius Wiesmann, Marijne Vermeer, Pau Jorba Adolff, Elena Guido Vinzoni, Nicolás Gonzalo Núñez, Colin Sparano, Viola Katharina Vetter, Ekaterina Friebel et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Immunotherapeutic strategies in hepatopancreatobiliary cancers
Massimiliano Salati, Alessandro Rizzo, Angela Dalia Ricci, Angelica Petrillo, Alessandro Parisi · 2024 · Elsevier eBooks
Immunotherapy for Pancreatic Cancer
Yoshiaki Sunami, Simon Rieder, Patrick Michl, Jorg H. Kleeff · 2025 · Springer eBooks
Localized Delivery of Anti‐CD40/PD‐1 Immunotherapy via a Polymeric Implant is Efficacious, Remodels the Tumor Immune Microenvironment and Improves Safety in a PDAC Mouse Model
Elahe Minaei, Samantha J. Wade, Chelsea Penney, Marie Ranson, Morteza Aghmesheh, Ronald Sluyter, Kara L. Vine · 2025 · Advanced Healthcare Materials
CD154 Restricts Helminth‐Induced Macrophage Polarisation and Proliferation While Promoting Tissue Residence
Mariana Suárez‐Martins, James E Parkinson, Lili Zhang, Brian H. K. Chan, Georgia Baldwin, Rebecca J. Dodd, Conor M. Finlay, Pedro Henrique Papotto, Judith E. Allen, Álvaro Díaz · 2025 · Parasite Immunology
Cross‐Cancer Perspectives on CD40 Agonist Therapy: Modulating the Tumor Immune Microenvironment
华旭东, Junyan Hua, Yanzhong Wang · 2026 · Journal of Biochemical and Molecular Toxicology
Docetaxel‐Induced Immune Activation Shows Antitumor Synergy With the Tumor‐Targeted CD40 Agonist KK2269
Yuta Tezuka, Kyoko Kawasaki, Yoshiki Sumitomo, Masato Saito, Akari Yao, Munetoshi Ando · 2026 · Cancer Science
Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study
Salah-Eddine Bentebibel, Daniel James McGrail, Veena Kochat, Emre Arslan, Reham Abdel‐Wahab, Barbara Pazdrak, Ravi Murthy, Nourel Hoda Tahon, S H Cho, Dzifa Y. Duose et al. · 2026 · Cancer Discovery
Macrophage-directed therapeutic strategies in cancer
Shweta Joshi, Judith A. Varner · 2026 · Trends in cancer
Cellular Indoctrination: How the Tumor Microenvironment Reeducates Macrophages Towards Nefarious Ends
Amy A. Powers, Seth H. Eisenberg, Katherine Elizabeth Jones, Laura P. Stabile, Michael T. Lotze, Rajeev Dhupar, Adam C. Soloff · 2021 · Elsevier eBooks
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences
Burcu Gurun, Wesley R. Horton, Dhaarini Murugan, Biqing Zhu, Patrick Leyshock, Sushil Kumar, Katelyn T. Byrne, Robert H. Vonderheide, Adam A. Margolin, Motomi Mori et al. · 2023 · BMC Genomics
Reliable prognostic definition and immunotherapy response prediction in bladder cancer, based on a novel aging-associated 5-gene signature model
Wei Meng, Ningning Li, Bo Chen, Huajun Zhang, Limin Ma, Yangbo Guan · 2024 · Translational Andrology and Urology
The engineered agonistic anti-CD40 antibody potentiates the antitumor effects of β-glucan by resetting TAMs
Wanpeng Cheng, Ziyi Huang, Yongzhe Hao, Hui Hua, Bo Zhang, Xiangyang Li, Fengqing Fu, Jing Yang, Kuiyang Zheng, Xueguang Zhang et al. · 2024 · Immunology Letters
Macrophage IL-4 polarization is restricted by soluble CD40 agonists and antigen-induced CD154 but not by constitutive CD154 expressed by CD4+ T cells
Mariana Suárez‐Martins, Ignacio González-Alayón, Cecilia Casaravilla, Louis Boon, Pedro Henrique Papotto, Conor M. Finlay, Stephen John Jenkins, Judith E. Allen, Álvaro Díaz · 2025 · Journal of Leukocyte Biology
Immunotherapy in Pancreatic Cancer
Bassel F. El‐Rayes, Mehmet Akce · 2020 · Digestive Disease Interventions
Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma Using Autophagy Inhibition, MEK blockade and CD40 Agonism
Honglin Jiang, Tristan Courau, Leonard C. Lupin-Jimenez, Joseph Borison, Alexa J. Ritchie, Aaron T. Mayer, Matthew F. Krummel, Eric Andrew Collisson · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Mapping intratumoral myeloid-T cell interactomes at single-cell resolution reveals targets for overcoming checkpoint inhibitor resistance
Kate Bridges, Gabriela A. Pizzurro, Alev Baysoy, Janani P. Baskaran, Ziyan Zoe Xu, Varsha Mathew, Victoria Tripple, Michael LaPorte, Koonam Park, William Damsky et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Congrès de l’association américaine de recherche contre le cancer — AACR 2016
Cécile Vicier, Éléonore De Guillebon, A. Kieffer, Anthony Turpin, Clément Dumont, Audrey Bellesœur, Daniele Grazziotin Soares, Jean‐Pierre Lotz · 2016 · ONCOLOGIE
Anti-CD40/Anti-CD40L
David S. Kotlyar, Anthony Joseph Leonardi · 2016 · Springer eBooks
Targeting the Immune System in Pancreatic Cancer
Derya Kabacaoğlu, Dietrich Alexander Ruess, Hana Algül · 2020 · Molecular and translational medicine
Perancangan Aplikasi Sistem Pakar Untuk Diagnosis Penyakit Ginjal Dengan Kombinasi Metode Certainty Factor Dan Metode Forward Chaining
Rumondang Silalahi · 2011
Congrès de l’association américaine de recherche contre le cancer — AACR 2018
Sandra Assoun, Marc‐Antoine Benderra, Arthur Géraud, A. Bayle, Alice Boilève, Daniele Grazziotin Soares, Jean‐Pierre Lotz · 2018 · ONCOLOGIE
Anti-CD40/Anti-CD40L
David S. Kotlyar, Anthony Joseph Leonardi · 2017 · Springer eBooks
Tumor-Specific CD4 T Cells Instruct Monocyte Differentiation in Pancreatic Ductal Adenocarcinoma
Michael T. Patterson, Adam L. Burrack, Yingzheng Xu, Zoe C. Schmiechen, Patricia R. Schrank, Ainsley E. Kennedy, Maria M. Firulyova, Ebony A. Miller, Eduardo Cruz-Hinojoza, Konstantin Zaitsev et al. · 2022 · SSRN Electronic Journal
Low TFPI2 expression is associated with poor prognosis and defective immune cell infiltration in breast cancer disease
Cheng Zhu, Ying Dai, Yanyan Zhang, Hua Wang, Xiaolei Hu · 2022 · Research Square
The Prospects of Immunotherapy in Pancreatic Cancer
Haoqiang Ying, Wantong Yao · 2022 · Springer eBooks
Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Éva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E.I. Hamouda et al. · 2023
Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Éva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E.I. Hamouda et al. · 2023
Data from CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors
Sara Labiano, Vincent Roh, Céline Godfroid, Agnès Hiou‐Feige, Jackeline F. Romero, Eva Sum, Moritz Rapp, Gaël Boivin, Tania Wyss, Christian Simon et al. · 2023
Data from CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors
Sara Labiano, Vincent Roh, Céline Godfroid, Agnès Hiou‐Feige, Jackeline F. Romero, Eva Sum, Moritz Rapp, Gaël Boivin, Tania Wyss, Christian Simon et al. · 2023
Data from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Mark S. Diamond, Jeffrey Lin, Robert H. Vonderheide · 2023
Data from A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor Regression
Nicolò Rigamonti, Niina Veitonmäki, Clara Domke, Sophie Barsin, Sarah Jetzer, Omar Abdelmotaleb, Ralph Bessey, Tamara Lekishvili, Francesca Malvezzi, Mariam A. Gachechiladze et al. · 2023
Systemic Oncosphere: Host Innate Immune System
Phei Er Saw, Erwei Song · 2023 · Springer eBooks
Immunotherapy for Pancreatic Cancer
Arsen Osipov, Adrian Gerard Murphy, Lei Zheng · 2023 · Wiley eBooks
Immune-Checkpoint Inhibitors: A New Line of Attack in Triple-Negative Breast Cancer
Ouissam Al Jarroudi, Khalid El Bairi, Giuseppe Curigliano, Saïd Afqir · 2023 · Cancer treatment and research
Additional file 4 of An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences
Burcu Gurun, Wesley R. Horton, Dhaarini Murugan, Biqing Zhu, Patrick Leyshock, Sushil Kumar, Katelyn T. Byrne, Robert H. Vonderheide, Adam A. Margolin, Motomi Mori et al. · 2023 · Figshare
Safety, Efficacy, and Biomarker Results of a Phase 1b/2 Study Combining the CD40 Agonist Mitazalimab with mFOLFIRINOX in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC); Results of the OPTIMIZE-1 Trial
Jean‐Luc Van Laethem, Ivan Borbath, Hans Prenen, Karen Paula Geboes, Aurélien Lambert, Emmanuel Mitry, Philippe Alexandre Cassier, Jean‐Frédéric Blanc, Lorenzo Pilla, Jaime Feliu Batlle et al. · 2024 · SSRN Electronic Journal
Overcoming immunotherapeutic drug resistance in pancreatic and colon cancers
Mario Tavakoli, Hasan Raza, Dirin Ukwade, Dexter Nwachukwu, Salimah Mohamed, Saeed Ali · 2025 · Elsevier eBooks
Advancing cancer immunotherapy through novel CD40-focused antibody engineering platforms
Barnabas Nyesiga · 2025
CD40 promotes AML survival via non-canonical NF-κB signaling and aberrant lipid metabolism
Li Zhang, Xin Luo, Dongyan Wu, Qiang Zhou, Jiachun Qiu, Muxia Yan, Yiqian Wang · 2025 · International Immunopharmacology
ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell–Dependent Tumor Immunity and Synergizes with PD-1 Blockade
Hampus Andersson, Ida Elin Maria Uddback, Tova Hermodsson, Mona Celander, Amulya Krishna Shetty, Lill Ljung, Anneli Nilsson, Anette Sundstedt, Laura von Schantz, Laura A. Varas et al. · 2025 · Cancer Immunology Research
Oxaliplatin and/or gemcitabine vs. FOLFIRINOX in first-line Advanced pancreatic adenocarcinoma: Real-world efficacy and safety data of moroccan patients
Hassan Abdelilah Tafenzi, Youssef Ait Takniouine, Ismail Essadi, Rhizlane Belbaraka · 2025 · Cancer Treatment and Research Communications
CD40 drives tumor growth in non-small cell lung cancer via non-canonical immune-independent mechanisms
Yujie Liu, Chandra Bhushan Prasad, Zhaojun Qiu, Deepika Singh, Nicholas L. Bean, Shravya Honne, Xiaoli Zhang, Chunhong Yan, Zaibo Li, Baek Kim et al. · 2025 · Cancer Letters
Additional file 1 of C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer
Sasaki, Kosuke, Takano, Shigetsugu, Satoshi Tomizawa, Miyahara, Yoji, Furukawa, Katsunori, Takayashiki, Tsukasa, Kuboki, Satoshi, Takada, Mamoru, Masayuki Ohtsuka · 2021 · Figshare
Additional file 3 of An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences
Burcu Gurun, Wesley R. Horton, Dhaarini Murugan, Zhu, Biqing, Patrick Leyshock, Sushil Kumar, Katelyn T. Byrne, Robert H. Vonderheide, Adam A. Margolin, Motomi Mori et al. · 2023 · Figshare
Additional file 3 of C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer
Sasaki, Kosuke, Takano, Shigetsugu, Satoshi Tomizawa, Miyahara, Yoji, Furukawa, Katsunori, Takayashiki, Tsukasa, Kuboki, Satoshi, Takada, Mamoru, Masayuki Ohtsuka · 2021 · Figshare
Additional file 2 of C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer
Sasaki, Kosuke, Takano, Shigetsugu, Satoshi Tomizawa, Miyahara, Yoji, Furukawa, Katsunori, Takayashiki, Tsukasa, Kuboki, Satoshi, Takada, Mamoru, Masayuki Ohtsuka · 2021 · Figshare
Additional file 2 of An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences
Burcu Gurun, Wesley R. Horton, Dhaarini Murugan, Zhu, Biqing, Patrick Leyshock, Sushil Kumar, Katelyn T. Byrne, Robert H. Vonderheide, Adam A. Margolin, Motomi Mori et al. · 2023 · Figshare
Additional file 1 of An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences
Burcu Gurun, Wesley R. Horton, Dhaarini Murugan, Zhu, Biqing, Patrick Leyshock, Sushil Kumar, Katelyn T. Byrne, Robert H. Vonderheide, Adam A. Margolin, Motomi Mori et al. · 2023 · Figshare
Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis
Minyan Ye, Yinuo Dong, Xiaoyun Li, Yang Zhi, Yuping Lu, Jieting Tang, Wei Hong Zhong, Xiaohong Lei, Yimin Mao, Sha Huang et al. · 2026 · Frontiers in Immunology
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy
Matthew P. Zimmerman, Amy Y. Huang, Emily K. Cox, Rose Al Abosy, Wan Lin Chong, Alex Bastian, Katherine J. Vietor, Yacine A. Choutri, Jenna L. Collier, Vasyl Zhabotynsky et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Integrated single-cell and functional analyses define strategies to enhance dendritic cell immunostimulatory capacity
Yuting Li, Huanhuan Li, Chao Li, Rongrui Liu, Sisi Ye, Juan Li, Chuanhua Zhao, Xiaomin Ma, Xudong Cheng, Jianming Xu · 2026 · Discover Oncology
Tumor Microenvironment in Pancreato-biliary Cancers: Crosstalk, Complexity, and Therapeutic Opportunities
Parthiban R, E. Bhavya, Teja Reddy Gujjula, Mohan Raj Vijayan, Krishnapriya Nandakumar, Akshaya Murugathirumal, Sanjay Valliappan · 2026 · Journal of Bio-X Research
CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting
Songul Kucukcelebi, Aniek E. van Diepen, Judith de Vos‐Geelen, Casper H.J. van Eijck, Nadine van Montfoort, Casper W.F. van Eijck · 2026 · Cancers
Correlated expression of MYBL2 and CCL5 defines an immunosuppressive microenvironment and predicts poor prognosis in intrahepatic cholangiocarcinoma
Junkai Ren, Sicheng Xu, Xing He, H J Ye, Wenbin Li · 2026 · BMC Cancer
The pivotal role of macrophages in tumorigenesis and pioneering cancer immunotherapy across pre-clinical and clinical frontiers
Mina Alimohammadi, Amir Mohammad Mirnejad, Najma Farahani, Neda Hedayati, Kiavash Hushmandi · 2026 · Journal of Cancer Research and Clinical Oncology
Emerging Precision Therapeutic Strategies in Pancreatic Ductal Adenocarcinoma: KRAS Targeting, DDR Vulnerabilities, Immune Redirection, and Tumor Microenvironment Remodeling
Jun Kim, Seounghun Kang · 2026 · Pharmaceutics
Enhanced antitumor efficacy through combined chimeric antigen receptor T cell therapy and CD40 stimulation in syngeneic solid tumor models
Giulia Golinelli, Ting–Jia Fan, Khatuna Gabunia, Wesley V. Wilson, Charles‐Antoine Assenmacher, He N Xu, Diego Gonzalves, Sofia Castelli, Jordan Reff, David Mai et al. · 2026 · Cytotherapy
ALDH1 inhibition by DIMATE maintains immune responses and promotes immunogenic remodeling in AML
Céline Baier, Julien Colle, Yasmine Labiad, Pascal Rihet, Mileidys Pérez‐Alea, Béatrice Loriod, Ismail Ceylan, Geoffroy Venton, Guillaume Martin, Régis T. Costello · 2026 · Frontiers in Immunology
B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity
Kendrick Nguyen, Monika Quackenbush, Sara Basbous, Haley Rodriguez, Georgia Lattanzi, Elsie Quansah, Chynna Rose Bowman, Sammy Weiser Novak, Daniela Boassa, Jingting Yu et al. · 2026 · Cell Reports